Dihydropyrimidinase Deficiency, a Progressive Neurological Disorder?
Author(s) -
Christopher M. Putman,
Jan J. Rotteveel,
Ron A. Wevers,
Albert van Gennip,
J. A. J. M. Bakkeren,
Ronney A. De Abreu
Publication year - 1997
Publication title -
neuropediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.656
H-Index - 67
eISSN - 1439-1899
pISSN - 0174-304X
DOI - 10.1055/s-2007-973681
Subject(s) - medicine , atrophy , magnetic resonance imaging , biopsy , pathology , pediatrics , radiology
A case of a child presenting with congenital abnormalities at birth is reported. The early development remained severely retarded and acquired skills minimally. The head circumference centile decreased. Magnetic resonance imaging showed progressive neuronal atrophy and secondary delay in myelination. Dihydropyrimidine concentrations in body fluids were quantitated by NMR spectroscopy. Enzymatic assay in the liver biopsy revealed total deficiency of dihydropyrimidinase (DHP) (5,6-dihydropyrimidine amidohydrolase; EC 3.5.2.2). As such, the patient is the first with enzymatically proven DHP deficiency. Thus far dihydropyrimidinuria has been reported in three other patients with a variety of neurological abnormalities. A relation of the enzyme deficiency with the neurodegenerative clinical course in our patient is suggested.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom